STABILITY AND CHARACTERIZATION
Our integrated research, formulation, product development, and manufacturing teams work closely together to anticipate challenges that hinder global accessibility and availability of critical immune-enhancing products.
CHARACTERIZATION OF SMALL MOLECULES, MACROMOLECULE, AND VACCINE ADJUVANT FORMULATIONS
ANALYTICAL ASSAY DEVELOPMENT
Development of analytical assays to characterize the material of interest, including HPLC assays, ELISA, and other biophysical assays.